ARTICLE
7 March 2025

Holland & Knight Health Dose: March 4, 2025

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Looking Ahead: Congress Faces Funding Deadline
  • Hearings This Week
  • Week in Review
  • Executive Order Updates
  • Reconciliation
  • Senate HELP Committee to Hold Confirmation Hearing on FDA, NIH Nominees
  • Accelerating Kids' Access to Care and Give Kids a Chance Act Reintroduced
  • Telehealth Expansion Act of 2025
  • Senate Judiciary Committee Chairman Grassley (R-Iowa) Requests Additional Information from Major Insurer on Medicare Billing Practices
  • House Hearing on PBMs
  • Office of Personnel Management (OPM) Releases Memorandum Directing Agency Reorganization Plans
  • HHS Issues Policy Statement on Administrative Procedure Act (APA)
  • Major PBM Ordered to Share Documents with Federal Trade Commission (FTC)
  • Tariffs on Mexico, Canada and China to take effect March 4, 2025

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More